Semaglutide Side Effects: What to Expect and When to Call

Most semaglutide side effects are digestive, and most of them fade. In the FDA trials behind Wegovy, 44% of adults reported nausea, 30% had diarrhea, and 24% had constipation. Serious problems stay uncommon. Nausea is what our patients ask about first, and it is usually the symptom that settles fastest. Here’s what the common side effects feel like, and which symptoms need medical attention. We keep the ramp gentle at Foundation Wellness in American Fork, Utah.

What Are the Most Common Semaglutide Side Effects?

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. It slows how fast your stomach empties and quiets the appetite signals your brain sends out. That same mechanism is where the common side effects come from.

The table below comes straight from the FDA prescribing information for Wegovy, pooled across weight-management clinical trials in adults.

Two things jump out of that table. Placebo rates are nowhere near zero, so a share of what people feel is ordinary life rather than the medication. The gap is still real, though. Nausea runs close to three times as common on semaglutide.

Dose drives a lot of this. At the lower diabetes doses used for Ozempic injection, nausea was reported by roughly 16% of people on 0.5 mg and 20% on 1 mg. Higher dose, more stomach symptoms.

Hair loss turns up in reports too. It usually tracks with rapid weight loss rather than the medication itself, and it tends to recover once your weight settles.

Most people ride all of this out. In those same clinical trials, 6.8% of adults stopped treatment because of adverse effects, against 3.2% on placebo. Nausea drove 1.8% of the exits, vomiting 1.2%, and diarrhea 0.7%.

What Does the First Month on a Semaglutide Injection Feel Like?

You start low on purpose. The FDA label sets a starting dose of 0.25 mg once weekly for weeks 1 through 4. From there the semaglutide injection steps up every four weeks. The ladder runs 0.5 mg, then 1 mg, then 1.7 mg, then 2.4 mg for maintenance.

That ladder exists for one reason. A slow ramp cuts the gastrointestinal side effect risk that comes with jumping straight to a high dose of any GLP-1 drug.

Most people barely notice week one. The first real test lands a day or two after a step up, when nausea peaks and then fades before the next increase. Think of it as a wave, not a wall.

If a step is rough, we hold you there. The label lets a provider delay escalation by four weeks, and we use that option often. There’s no prize for rushing the ladder. In our experience, a held dose costs a few weeks and saves the whole plan, while pushing through a miserable step is what makes people walk away from treatment entirely.

What about a missed dose? Take it if you remember within five days, then return to your usual injection day. Past five days, skip that one and resume the normal schedule. Don’t double up to catch up.

Injection site reactions stay minor for most people, usually a little redness or itching where the needle went in. Rotating each injection between the abdomen, thigh, and upper arm helps a lot. Pushing the plunger slowly, over five to ten seconds, also cuts the sting at the injection site.

Keep a short note on your phone for the first eight weeks. Jot down the injection date, the dose, and any symptoms that showed up in the next 48 hours. That record turns a vague “week three was pretty rough” into a pattern we can act on. Our team reads it back with you at the next check-in, and that is usually where the fix comes from. It also makes the choice to hold or advance an easy one.

Can Semaglutide Cause Low Blood Sugar?

By itself, rarely. Semaglutide prompts insulin release mainly when blood sugar is already high. It doesn’t push your blood sugar level down the way injected insulin can.

The picture changes when semaglutide sits beside another diabetes medication. Insulin and sulfonylureas such as glipizide or glyburide can combine with a GLP-1 to cause low blood sugar, sometimes severe. The FDA label tells providers to inform every patient of that risk and to consider lowering the insulin dose first.

Learn these low blood sugar symptoms before your first injection:

• Shakiness, sweating, or a racing heart.
• Sudden hunger or lightheadedness.
• Blurred vision or trouble concentrating.
• Irritability that shows up out of nowhere.

Treat symptoms early with 15 grams of fast carbohydrate, then recheck in 15 minutes. Keeping glucose tablets in the car is a small habit worth building if you drive for work.

If you live with type 2 diabetes, we coordinate with whoever manages your diabetes before you start. We ask you to check blood sugar more often during the ramp, especially in the days right after each step up. Our patients on insulin or a sulfonylurea hear that reminder at every visit, not only the first one. Plenty of people with type 2 diabetes end up cutting their other diabetes medicine as semaglutide takes hold and blood sugar steadies.

Without type 2 diabetes, low blood sugar stays uncommon. Skipping meals because your appetite vanished is still worth avoiding. That’s where the lightheadedness usually starts.

Which Semaglutide Side Effects Are Serious?

Serious problems are uncommon, and each one carries symptoms worth memorizing. The FDA lists these in the warnings section of the label.

• Pancreatitis. Severe abdominal pain that won’t ease, sometimes radiating to the back, with or without vomiting. Stop the medication and seek medical attention.
• Gallbladder disease. Pain in the upper right belly, fever, yellowing skin, or clay-colored stools. These symptoms tend to build over hours. Rapid weight loss raises gallstone risk on its own.
• Kidney injury from dehydration. Several days of vomiting or diarrhea can dry you out and strain the kidneys.
• Allergic reaction. Anaphylaxis and angioedema have been reported since approval. The label says to stop the drug and promptly seek medical advice when an allergic reaction is suspected.
• Severe delayed stomach emptying. Semaglutide isn’t appropriate for anyone with severe gastroparesis.

Dehydration symptoms are the ones people miss most: dark urine, a dry mouth, dizziness when you stand up. Two days of vomiting can get you there faster than you’d guess. Pausing the medication for a week while you rehydrate is a normal step, not a failure.

One warning surprises almost every patient we treat. Tell your surgeon, anesthesiologist, or dentist that you take a GLP-1 before any procedure involving anesthesia or deep sedation. Because the medication slows stomach emptying, food can still be sitting there and come back up into the lungs. Most surgical teams now ask about this medication by name.

The boxed warning covers thyroid C-cell tumors seen in rodent studies. Semaglutide isn’t for anyone with a personal or family history of medullary thyroid carcinoma, or with MEN 2 syndrome. We screen that history, along with your other health conditions, before writing a single prescription. Our team asks about it twice, once on the intake form and once out loud, because people often forget what a relative was treated for years ago.

Who Should Not Take Semaglutide?

Some people should skip this drug entirely, and a careful screening visit catches that in about twenty minutes.

• A personal or family history of medullary thyroid carcinoma, or MEN 2 syndrome.
• A previous serious allergic reaction to semaglutide or another GLP-1.
• Severe gastroparesis, or another condition that already delays stomach emptying.
• Pregnancy, or plans to become pregnant in the next few months.

That last one carries a specific rule. Because semaglutide has a long half-life, the label says to stop it at least two months before a planned pregnancy. Novo Nordisk also runs a pregnancy exposure registry for anyone who conceives while taking it. Breastfeeding isn’t recommended during treatment either.

A history of pancreatitis, gallstones, or kidney disease doesn’t rule you out on its own. It changes how closely we watch you and how slowly we move. Tell us about all your health conditions, including the ones you assume are unrelated.

Does Semaglutide Affect Your Eyes or Your Heart?

Both questions come up, and both deserve a straight answer instead of reassurance.

A two-year trial studied semaglutide in adults with type 2 diabetes and existing cardiovascular disease. Diabetic retinopathy complications occurred in 3% of that group, versus 1.8% on placebo. The signal concentrated in people who already had diabetic retinopathy: 8.2% versus 5.2%. Among those with no known history, the rate was 0.7%. Fast drops in blood sugar are a recognized trigger for retinopathy changes.

The practical takeaway is simple. If you have type 2 diabetes and any eye disease, get a dilated exam before your first dose and keep your eye health appointments through the ramp. Early retinopathy rarely causes symptoms you’d notice. That’s exactly why the exam matters more than how your vision feels.

On the heart side, semaglutide can nudge resting heart rate up by a few beats per minute, so we check it at every visit. The same class has also shown benefit against cardiovascular disease outcomes. That’s why cardiologists now prescribe these drugs alongside standard care.

Does Semaglutide Change Your Face?

You’ve probably seen the phrase “Ozempic face” somewhere online. It describes the hollow, deflated look some people notice in the cheeks and temples after fast weight loss.

This is not a drug reaction. Fat leaves the face the same way it leaves everywhere else, and faces show it first. Older skin has less elastic recoil, so the change reads stronger after 40.

Two things soften it. Losing weight at a steady pace rather than a sprint gives skin time to adapt. Getting enough protein and lifting something heavy twice a week protects lean mass, which matters far more than any cream.

Hair loss follows the same pattern. It shows up a few months into rapid weight loss, then recovers as your weight and nutrition level out.

Is Compounded Semaglutide Riskier Than a Brand Pen?

It can be, and the reason is unglamorous: measurement. Compounded semaglutide usually arrives in a vial, and you draw each dose yourself with a syringe.

In July 2024 the FDA issued an alert about dosing errors with compounded injectable semaglutide products. Some people drew five to ten times the intended dose after confusing milligrams, units, and milliliters. In the worst reports, an inexperienced patient drew as much as twenty times the intended amount. Adverse effects from those overdoses included vomiting, stomach pain, dehydration, fainting, and hospital admission.

That isn’t proof that every compounded medication is unsafe. It’s an argument for supervision. If you use compounded medications, you want a provider who hands you the right syringe size. You want them to write the dose in units, then watch you draw it at least once.

Compounding pharmacies also sit outside the FDA approval process. Potency and purity aren’t verified the same way they are for an approved product. We walk through that tradeoff honestly rather than pretending it doesn’t exist. Our patients who arrive already using a compounded vial get the same walkthrough anyway: correct syringe size, the dose written down in units, and one draw done in front of us before they go home.

How Do You Ease the Common Side Effects?

Small habits carry most of the load. Here’s what our patients report actually working during the first two months.

The biggest lever is still the ramp itself. Rushing to a higher dose turns a manageable potential side effect into a miserable week. It rarely speeds up results anyway.

Timing helps as well. Some people move their weekly injection to Friday so the quietest stomach days land on the weekend. Others find the reverse works better. Either way, keeping the same injection day each week makes the pattern easier to read.

Reflux symptoms usually answer to timing rather than another medication. Stop eating three hours before bed and the problem often fades on its own.

Constipation is the one common side effect people tend to ignore until it gets uncomfortable. Deal with it early and the rest of the ramp goes better.

What Should You Eat While the Nausea Lasts?

Volume is the problem, not food itself. Your stomach empties slower now, so the same plate that felt normal a month ago feels like too much today.

Lean on these habits during the week after every step up:

• Eat protein first, then vegetables, then starch.
• Aim for four small meals instead of two large ones.
• Stop at the first hint of full, not at the clean plate.
• Skip fried food, cream sauces, and big portions of red meat.
• Sip water through the day rather than gulping it at meals.

Cold or room-temperature food often sits better than hot food, mostly because it carries less smell. Plain crackers, yogurt, and clear broth are the standbys our patients keep coming back to. Ginger tea helps some people and does nothing for others, which is fine either way.

Protein deserves its own line here. Appetite drops fast on a semaglutide injection, and it’s easy to drift down to 40 grams of protein a day without noticing. That’s where fatigue and lost muscle usually begin.

What Happens When You Stop Semaglutide?

The side effects fade fairly quickly. Nausea and constipation settle over a few weeks as the drug clears, though the long half-life means it leaves your system slowly.

Appetite is the harder part. In the STEP 1 trial extension, published in 2022, participants regained about two-thirds of their lost weight during the year after they stopped. Improvements in blood pressure, cholesterol, and blood sugar drifted back toward the starting point.

That result isn’t a reason to fear the drug. It’s a reason to treat weight as an ongoing condition rather than a 12-week project. We plan the exit at the same visit where we plan the start, whether that means a maintenance dose, a slow taper, or a handoff to diet and strength work. That sequence is something we learned the hard way: an exit plan written at the end lands as bad news, while the same plan written on day one reads as the map.

When Should You Seek Medical Attention?

Call the clinic when symptoms cross from annoying into alarming. That list includes severe abdominal pain that won’t let up, or vomiting you can’t stay ahead of. It also covers signs of dehydration, a rash with swelling of the face or throat, or low blood sugar you can’t correct with food.

Speak up about the smaller stuff too. Ongoing nausea, constipation that won’t budge, or fatigue that flattens your week are all fixable. None of those require urgent medical attention. Adjusting the plan beats quitting on your own, and the adjustment is usually a dose hold rather than a full stop.

According to the National Institute of Diabetes and Digestive and Kidney Diseases, weight-management medication works best next to steady changes in how you eat and move. That’s the part no injection does for you.

Bring your full medication list to the first visit, supplements included, since a few of them interact with a GLP-1. Every plan we build accounts for your other medication, your history, and your goals. You can see how the monitored program runs on our GLP-1 weight loss in Utah page. Compare the two drugs on our semaglutide vs tirzepatide guide, or check pricing on the GLP-1 cost in Utah page. You can also see where this fits inside medical weight optimization. Foundation Wellness treats patients across American Fork, Provo, and the rest of Utah County. Call us when you’re ready to start.

Key Takeaways

• Common semaglutide side effects are digestive: nausea at 44%, diarrhea at 30%, vomiting and constipation at 24% each in the Wegovy clinical trials.
• Nausea peaks in the day or two after each step up, then fades before the next increase.
• The 0.25 mg to 2.4 mg ladder over 16 weeks exists to limit stomach symptoms. Holding a dose for four extra weeks is a normal move.
• Low blood sugar is rare on semaglutide alone but real when combined with insulin or a sulfonylurea for type 2 diabetes.
• Unrelenting belly pain, an allergic reaction, or ongoing vomiting deserve prompt medical attention.
• Track your dose, your injection date, and any symptoms for the first eight weeks so patterns show up early.
• Anyone with type 2 diabetes and eye disease should have a dilated exam before starting, because of the diabetic retinopathy signal.
• Compounded vials add a dosing-error risk that supervision and the right syringe size largely solve.
• Foundation Wellness serves American Fork and the rest of Utah, in person and by telehealth.

Sources

• U.S. Food and Drug Administration, Wegovy (semaglutide) prescribing information, sections 2, 5, 6 and 8 - dailymed.nlm.nih.gov
• U.S. Food and Drug Administration, alert on dosing errors with compounded injectable semaglutide - fda.gov
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - niddk.nih.gov
• U.S. Food and Drug Administration, Ozempic (semaglutide) approved label - accessdata.fda.gov
• Wilding et al., “Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension,” Diabetes, Obesity and Metabolism, 2022 - pubmed.ncbi.nlm.nih.gov